Objectives: Midkine is a heparin-binding growth factor which functions in development and repair mechanisms. It also has roles in tumor growth, invasion and angiogenesis in cancer cells. Recently, higher serum midkine levels were detected in inflammatory diseases such as rheumatoid arthritis, inflammatory bowel diseases, atherosclerosis and obesity. In the present study, we aimed to investigate serum midkine levels in patients with psoriasis. We also tried to reveal if there is a relationship between serum midkine levels and psoriasis disease activity. Material and Methods: Forty-five patients with psoriasis and age, sex-matched healthy controls were enrolled in the study. Serum midkine level, complete blood count, fasting serum glucose level, lipid profile (HDL, LDL, triglyceride, cholesterol), CRP (C-reactive protein), serum liver function tests (ALT; AST) and kidney function tests (urea and creatinine) were studied. Psoriasis area severity index (PASI) scores and body mass indexes were calculated for each patient. Results: We found significantly higher serum midkine levels in patients with psoriasis compared to control group. There was no correlation between serum midkine levels and PASI scores. Serum midkine levels were correlated with serum triglyceride levels in patients with psoriasis. Conclusion: This study showed that serum midkine levels were significantly higher in psoriatic patients than controls. As midkine is only correlated with serum triglyceride level and not correlated with PASI, we think serum midkine is not an ideal serum marker for the evaluation of psoriasis activity.
Keywords: Midkine; psoriasis; metabolic syndrome; inflammation
Amaç: Midkin, büyüme, gelişme ve tamir mekanizmalarında görevli bir büyüme faktörüdür. Ayrıca, kanser hücrelerinde tümör büyümesi, invazyon ve anjiyogenezden sorumludur. Son zamanlarda, romatoid artrit, inflamatuar bağırsak hastalıkları, ateroskleroz ve obezite gibi bircok inflamatuvar hastalıkta yüksek serum midkin seviyeleri tespit edilmiştir. Çalışmamızda, psöriyazisli hastalarda serum midkin seviyesini ve bu seviyelerin hastalık aktivitesi ile ilişkisini belirlemeyi hedefledik. Gereç ve Yöntemler: Psöriyazis tanısı almış 45 hasta ile yaş ve cinsiyet açısından eşleşmiş kontroller çalışmaya dahil edildi. Tüm hasta ve kontrollerde, serum midkin seviyeleri, tam kan sayımı, açlık kan şekeri, lipid profili (HDL, LDL, trigliserit, kolesterol), CRP (C reaktif protein), serum karaciğer testleri (ALT, AST) ve böbrek fonksiyon testleri (üre, kreatinin) çalışıldı. Her hasta için psöriyazis alan şiddet indeksi (PAŞİ) skorları ve vücut kitle indeksleri (VKİ) hesaplandı. Bulgular: Psöriyazisli hastalarda kontrol grubuna göre belirgin olarak daha yüksek serum midkin seviyeleri saptadık. Serum midkin seviyeleri ile PAŞİ skorları arasında korelasyon gözlemlemedik. Psöriyazisli hastalarda serum midkin seviyelerinin serum trigliserit seviyeleri ile korelasyon göstermekteydi. Sonuç: Bu çalışmada psöriyazisli hastalarda kontrollere göre istatistiksel olarak anlamlı seviyede daha yüksek serum midkine seviyeleri saptandı. Ancak serum midkin seviyelerinin trigliserit seviyeleri ile korelasyon gösterip, PAŞİ skorları ile korele olmaması nedeniyle, serum midkin seviyelerinin psöriyazis aktivitesi ve takibinde ideal bir belirteç olmadığını düşünmekteyiz.
Anahtar Kelimeler: Midkin; psöriyazis; metabolik sendrom; inflamasyon
- Kadomatsu K, Tomomura M, Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun. 1988;151(3):1312-8. [Crossref]
- Bădilă E, Daraban AM, Tintea E, Bartos D, Alexandru N, Georgescu A. Midkine proteins in cardio-vascular disease. Where do we come from and where are we heading to? Eur J Pharmacol. 2015;762:464-71. [Crossref] [PubMed]
- Muramatsu T. Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol. 1993;37(1):183-8.
- Weckbach LT, Groesser L, Borgolte J, Pagel JI, Pogoda F, Schymeinsky J, et al. Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis. Am J Physiol Heart Circ Physiol. 2012;303(4):H429-38. [Crossref] [PubMed]
- Meng Z, Tan J, Zhang G, Tian W, Fu Q, Li W, et al. Evaluation of serum midkine as a biomarker in differentiated thyroid cancer. Life Sci. 2015;130:18-24. [Crossref] [PubMed]
- Vongsuvanh R, van der Poorten D, Iseli T, Strasser SI, McCaughan GW, George J. Midkine increases diagnostic yield in AFP negative and NASH-related hepatocellular carcinoma. PLoS One. 2016;11(5):e0155800. [Crossref] [PubMed] [PMC]
- Yamashita T, Shimada H, Tanaka S, Araki K, Tomifuji M, Mizokami D, et al. Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma. Cancer Med. 2016;5(3):415-25. [Crossref] [PubMed] [PMC]
- Weckbach LT, Muramatsu T, Walzog B. Midkine in inflammation. ScientificWorldJournal. 2011;11:2491-505. [Crossref] [PubMed] [PMC]
- Krzystek-Korpacka M, Neubauer K, Matusiewicz M. Clinical relevance of circulating midkine in ulcerative colitis. Clin Chem Lab Med. 2009;47(9):1085-90. [Crossref] [PubMed]
- Fan N, Sun H, Wang Y, Zhang L, Xia Z, Peng L, et al. Midkine, a potential link between obesity and insulin resistance. PLoS One. 2014;9(2):e88299. [Crossref] [PubMed] [PMC]
- Parodi A, Aste N, Calvieri C, Cantoresi F, Carlesimo M, Fabbri P, et al. Metabolic syndrome prevalence in psoriasis: a cross-sectional study in the Italian population. Am J Clin Dermatol. 2014;15(4):371-7. [Crossref] [PubMed]
- Isha, Jain VK, Lal H. C-reactive protein and uric acid levels in patients with psoriasis. Indian J Clin Biochem. 2011;26(3):309-11. [Crossref] [PubMed] [PMC]
- Beygi S, Lajevardi V, Abedini R. C-reactive protein in psoriasis: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28(6):700-11. [Crossref] [PubMed]
- Monma F, Hozumi Y, Ikematsu S, Kawaguchi M, Kadomatsu K, Suzuki T. Expression of midkine in normal human skin, dermatitis and neoplasms: association with differentiation of keratinocytes. J Dermatol. 2013;40(12):980-6. [Crossref] [PubMed]
- Inazumi T, Tajima S, Nishikawa T, Kadomatsu K, Muramatsu H, Muramatsu T. Expression of the retinoid-inducible polypeptide, midkine, in human epidermal keratinocytes. Arch Dermatol Res. 1997;289(8):471-5. [Crossref] [PubMed]
- Jono H, Ando Y. Midkine: a novel prognostic biomarker for cancer. Cancers (Basel). 2010;2(2):624-41. [Crossref] [PubMed] [PMC]
- Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A, et al. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res. 1995;55(8):1792-7.
- Ota K, Fujimori H, Ueda M, Shiniriki S, Kudo M, Jono H, et al. Midkine as a prognostic biomarker in oral squamous cell carcinoma. Br J Cancer. 2008;99(4):655-62. [Crossref] [PubMed] [PMC]
- Busnelli M, Manzini S, Froio A, Vargiolu A, Cerrito MG, Smolenski RT, et al. Diet induced mild hypercholesterolemia in pigs: local and systemic inflammation, effects on vascular injury-rescue by high-dose statin treatment. PLoS One. 2013;8(11):e80588. [Crossref] [PubMed] [PMC]
- Milčić D, Janković S, Vesić S, Milinković M, Marinković J, Cirković A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study. An Bras Dermatol. 2017;92(1):46-51. [Crossref] [PubMed] [PMC]
- Curcó N, Barriendos N, Barahona MJ, Arteaga C, García M, Yordanov S, et al. Factors influencing cardiometabolic risk profile in patients with psoriasis. Australas J Dermatol. 2017;59(2):e93-8. [Crossref] [PubMed]
- Zindanci I, Albayrak O, Kavala M, Kocaturk E, Can B, Sudogan S, et al. Prevalence of metabolic syndrome in patients with psoriasis. ScientificWorldJournal. 2012;2012:312463. [Crossref] [PubMed] [PMC]
- Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157(1):68-73. [Crossref] [PubMed]
- Yazihan N. Midkine in inflammatory and toxic conditions. Curr Drug Deliv. 2013;10(1):54-7. [Crossref] [PubMed]
- Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin. 2015;33(1):41-55. [Crossref] [PubMed]
- Weckbach LT, Gola A, Winkelmann M, Jakob SM, Groesser L, Borgolte J, et al. The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via β2 integrins (CD11/CD18). Blood. 2014;123(12):1887-96. [Crossref] [PubMed]
- Takada T, Toriyama K, Muramatsu H, Song XJ, Torii S, Muramatsu T. Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem. 1997;122(2):453-8. [Crossref] [PubMed]
- Lucas S, Henze G, Schnabel D, Barthlen W, Sakuma S, Kurtz A, et al. Serum levels of Midkine in children and adolescents without malignant disease. Pediatr Int. 2010;52(1):75-9. [Crossref] [PubMed]
.: Process List